A R T I C L E S
Sims and Schmidt
known NRPS R domains and virtually all of their relatives in the
short chain dehydrogenase/reductase (SDR) superfamily catalyze
redox reactions, this proposal appeared to be strongly supported.33
Like these characterized reductive NRPS proteins, EqiS and other
pyrrolidine NRPSs contain adenylation (A) and thiolation (T)
domains, which activate amino acids as covalent enzyme-linked
thioesters,34 as well as condensation (C) domains, which catalyze
peptide bond formation.35 The NRPS proteins thus follow the
standard domain order CATR. Recently, the tenellin PKS was
heterologously expressed, resulting in tetramic acid formation.36
This result supported a second possibility, that tetramic acids
themselves are directly offloaded by this enzyme group via a
Dieckmann condensation (Figure 2). In this scenario, the genetic
basis for compound diversity would be less clear. However, as this
result was obtained in vivo, it remained possible that a reduction-
oxidation process occurred within whole fungal cells.
Since understanding the mechanism of tetramic acid formation
would allow improved drug discovery and biosynthetic engineering
in this important compound class, we set out to test these and other
possibilities using the equisetin biosynthetic gene cluster eqi from
F. heterosporum.19 Synthesis of intermediate analogs and kinetic
analysis using purified equisetin synthetase (EqiS) protein domains
revealed that the EqiS R domain is a Dieckmann cyclase, not a
reductase. The proposed chemical mechanism bears some similarity
to that catalyzed by thioesterase enzymes in PKS and NRPS
metabolism, indicating a new role for fungal NRPS R domains.
These results have implications for the evolution of the diverse
fungal polyketide-pyrrolidine-2-one compound family.
Figure 2. Proposed biogenesis of equisetin and possible roles of R domain.
A polyketide portion (blue) is synthesized by the PKS, whereas serine (red)
is appended by the NRPS. A covalently enzyme-bound thioester intermediate
is the substrate for R, which would cleave the intermediate from the enzyme.
R could catalyze a reduction, leading to an aldol reaction followed by
oxidation to give equisetin. Alternatively, it could function as a Dieckmann
cyclase. The timing of N-methylation is unclear.
synthetase (NRPS) hybrid, terminating in an apparently typical
NRPS reductive (R) domain (Figure 2). The PKS proteins appear
to be fungal highly reducing iterative synthases, which use the same
set of domains in an iterative manner to cobble together carbon
skeletons from acetyl- and malonyl-CoA.11,12,25–27 Prediction of
the resulting polyketide structure using gene sequences is beyond
current art, as all of these PKS genes appear quite similar despite
vastly different carbon skeletons. Subsequently, the NRPS
module is proposed to append an amino acid, resulting in a beta-
ketoamide aminoacetyl-thioester. This enzyme-bound thioester
intermediate is primed for cleavage to yield the final pyrrolidine-
2-one derivative. While the polyketide structural diversity is
likely controlled by the PKS, the genetic basis for pyrrolidine-
2-one diversity remained unclear.
Experimental Methods
Expression of EqiS Domains. Detailed experimental methods
for generating vectors, chemical synthesis, and other procedures
can be found in the Supporting Information. C-terminal domain
constructs of EqiS were expressed in E. coli, resulting in proteins
that were purified to homogeneity using Ni-NTA resin followed
by FPLC with a Superdex SD200 size exclusion column. This
column was also used on a series of size standards, allowing the
size of eluted proteins to be accurately estimated. Expressed proteins
included ATR, TR, and R domains fused to N-terminal 6×-His
tags. Purity of proteins was assessed by FPLC and SDS-PAGE.
TR was analyzed by ESI-MS: ESI-MS [M + H2O] 52784
(C2341H3707N651O709S14 [M + H2O] calcd 52783).
Two proposals have been advanced to explain the diverse pyr-
rolidine-2-ones in this class of fungal polyketide metabolites. NRPS
R domains have been characterized in a number of cases to reduce
enzyme-bound thioesters using NAD(P)H as a cofactor, resulting
in aldehydes or alcohols.28–32 In the pyrrolidine-2-one family, it
was possible that a reductive process would lead to a universal
aldol intermediate (Figure 2). This aldol could undergo a variety
of different fates, including oxidation back to the tetramic acid,
oxidation at another site to yield pyrrolidine-2-one derivatives, or
Diels-Alder cyclization to yield the cytochalasin family. Since the
R Domain Putative Substrate and Product Synthesis. For
mechanistic analysis, substrate analogs that were capable or
incapable of undergoing a Dieckmann condensation were synthe-
sized. Briefly, these consisted of acetoacetyl-alanine and acetyl-
alanine, respectively. To imitate covalent enzyme attachment, these
substrates were attached as thioesters to N-acetylcysteamine or
coenzyme A (CoA) using the transthiolation method.37 Thioester
substrates were purified to homogeneity by HPLC and characterized
by NMR and MS. Standards of putative products of enzymatic
(28) Ehmann, D. E.; Gehring, A. M.; Walsh, C. T. Biochemistry 1999, 38,
6171–6177.
(19) Sims, J. W.; Fillmore, J. P.; Warner, D. D.; Schmidt, E. W. Chem.
Commun. 2005, 186–188.
(29) Gaitatzis, N.; Kunze, B.; Mu¨ller, R. Proc. Natl. Acad. Sci. U.S.A. 2001,
98, 11136–11141.
(20) Eley, K. L.; Halo, L. M.; Song, Z.; Powles, H.; Cox, R. J.; Bailey,
A. M.; Lazarus, C. M.; Simpson, T. J. Chembiochem 2007, 8, 289–
297.
(30) Becker, J. E.; Moore, R. E.; Moore, B. S. Gene 2004, 325, 35–42.
(31) Kopp, F.; Mahlert, C.; Gru¨newald, J.; Marahiel, M. A. J. Am. Chem.
Soc. 2006, 128, 16478–16479.
(32) Read, J. A.; Walsh, C. T. J. Am. Chem. Soc. 2007, 129, 15762–15763.
(33) Oppermann, U.; Filling, C.; Hult, M.; Shafqat, N.; Wu, X.; Lindh,
M.; Shafqat, J.; Nordling, E.; Kallberg, Y.; Persson, B.; Jornvall, H.
Chem. Biol. Interact. 2003, 143-144, 247–253.
(34) Ehmann, D. E.; Shaw-Reid, C. A.; Losey, H. C.; Walsh, C. T. Proc.
Natl. Acad. Sci. U.S.A. 2000, 97, 2509–2514.
(35) Belshaw, P. J.; Walsh, C. T.; Stachelhaus, T. Science 1999, 284, 486–
489.
(36) Halo, L. M.; Marshall, J. W.; Yakasai, A. A.; Song, Z.; Butts, C. P.;
Crump, M. P.; Heneghan, M.; Bailey, A. M.; Simpson, T. J.; Lazarus,
C. M.; Cox, R. J. Chembiochem 2008, 9, 585–594.
(37) Vitali, F.; Zerbe, K.; Robinson, J. A. Chem. Commun. 2003, 2718–
2719.
(21) Schumann, J.; Hertweck, C. J. Am. Chem. Soc. 2007, 129, 9564–9565.
(22) Maiya, S.; Grundmann, A.; Li, X.; Li, S. M.; Turner, G. Chembiochem
2007, 8, 1736–1743.
(23) Bergmann, S.; Schumann, J.; Scherlach, K.; Lange, C.; Brakhage,
A. A.; Hertweck, C. Nat. Chem. Biol. 2007, 3, 213–217.
(24) Bohnert, H. U.; Fudal, I.; Dioh, W.; Tharreau, D.; Notteghem, J. L.;
Lebrun, M. H. Plant Cell 2004, 16, 2499–2513.
(25) Auclair, K.; Sutherland, A.; Kennedy, J.; Witter, D. J.; Van den Heever,
J. P.; Hutchinson, C. R.; Vederas, J. C. J. Am. Chem. Soc. 2000, 122,
11519–11520.
(26) Auclair, K.; Kennedy, J.; Hutchinson, C. R.; Vederas, J. C. Bioorg.
Med. Chem. Lett. 2001, 11, 1527–1531.
(27) Nicholson, T. P.; Rudd, B. A. M.; Dawson, M.; Lazarus, C. M.;
Simpson, T. J.; Cox, R. J. Chem. Biol. 2001, 8, 157–178.
9
11150 J. AM. CHEM. SOC. VOL. 130, NO. 33, 2008